繁體中文
張玉是雍禾醫療集團有限公司（聯交所主板上市，股份代號二二七九）的創辦人、執行董事、董事會主席兼首席執行官。公司二○二五年年報記載，他當年四十歲，負責集團整體戰略規劃、業務方向及運營管理，並出任提名委員會主席及薪酬委員會成員；他於二○二○年九月十七日獲委任為董事，二○二一年六月一日調任為執行董事。
年報記述，他投身醫療養固服務行業超過二十年，二○○五年三月進入植髮領域，加入北京楚蓉福運醫療美容診所，二○○七年十一月辭任，二○一○年七月創辦集團，以「雍禾」品牌開展植髮事業。他自二○二五年十月起擔任中國非公立醫療機構協會毛髮醫學專業委員會執行副會長兼秘書長，並自二○一八年九月起出任同一協會皮膚專業委員會毛髮醫學與頭皮健康管理學組副組長。他於二○○一年六月畢業於泗縣大莊初級中學。
集團業務由植髮擴展至多種毛髮相關疾病的診斷及治療、醫療及常規養護、假髮研究與生產等範疇。年報列明，其弟張輝為執行董事，負責整體採購管理及業務發展；董事會另有執行董事韓志梅，以及非執行董事耿嘉琦和三名獨立非執行董事。年報顯示，董事會由三名執行董事、一名非執行董事及三名獨立非執行董事組成，他自二○一○年七月起一直擔任集團首席執行官。
English
Zhang Yu is founder, executive director, chairman of the board and chief executive officer of Yonghe Medical Group, listed on the Main Board of the Hong Kong Stock Exchange under stock code 2279. The company's 2025 annual report records that he was 40 years old and that he is responsible for the group's overall strategic planning, business direction and operational management, while also chairing the nomination committee and serving on the remuneration committee. He was appointed a director on 17 September 2020 and re-designated an executive director on 1 June 2021.
The report states that he has spent more than 20 years in the medical hair-care industry. He entered the hair transplant field in March 2005 at Beijing Churong Fuyun Medical Cosmetology Clinic and left in November 2007; in July 2010 he founded the group and began building the Yonghe brand of hair transplant services. Since October 2025 he has been executive vice president and secretary-general of the hair medicine committee of the Chinese Non-Government Medical Institutions Association, and since September 2018 he has been deputy head of that association's hair medicine and scalp health management group under its dermatology committee. He graduated from Dazhuang Junior Middle School in Si County in June 2001.
The group has expanded from hair transplantation into the diagnosis and treatment of various hair-related conditions, medical and routine hair care, and wig research and production. The report identifies his younger brother Zhang Hui as an executive director in charge of procurement management and business development; the board also includes executive director Han Zhimei, non-executive director Geng Jiaqi and three independent non-executive directors.
